Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome.
Volume replacement was studied prospectively in 208 infants with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). The mean volume of intravenous fluid used was 110.4 mL/kg administered over a mean period of 25.8 hours. The mean volumes of intravenous fluid replacement in infants with DSS was significantly higher than in those with non-shock DHF (129.8 mL/kg versus 102.1 mL/kg; P = 0.001). Patients with DSS had significantly higher proportional requirements for dextran and blood transfusions than non-shock infants. Recurrent shock, prolonged shock, and acute respiratory failure were recorded in 8, 6, and 13 patients, respectively. Four patients with DSS died of severe complications. Intravenous fluid replacement with special care to avoid fluid overload requires careful attention to established indications for use of colloidal solutions and blood transfusions. To improve case fatality rates, special efforts need to be directed to infants with DHF/DSS accompanied by severe complications.
Nguyen
Thanh Hung
TH
Department of Dengue Hemorrhagic Fever, Children's Hospital No. 1, Ho Chi Minh City, Vietnam. hungdhf@hcm.fpt.vn
Nguyen
Trong Lan
TL
Lei
Huan-Yao
HY
Lin
Yee-Shin
YS
Le
Bich Lien
BL
Huang
Kao-Jean
KJ
Lin
Chiou-Feng
CF
Do
Quang Ha
QH
Vu
Thi Que Huong
TQ
Lam
Thi My
TM
Yeh
Trai-Ming
TM
Huang
Jyh-Hsiung
JH
Liu
Ching-Chuan
CC
Halstead
Scott B
SB
D001803:Blood Transfusion; D003911:Dextrans / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D008297:Male; D017063:Outcome Assessment, Health Care; D010952:Plasma Substitutes / Q000008:administration & dosage*; D011446:Prospective Studies; D019595:Severe Dengue / Q000473:pathology / Q000628:therapy*; D012720:Severity of Illness Index; D014744:Vietnam
D003911:Dextrans; D010952:Plasma Substitutes